9 results
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
22 Feb 24
Gracell Biotechnologies Acquisition Completed
8:50am
the completion of the Transactions; disruptions of current plans and operations caused by the completion of the Transactions; potential difficulties in employee … retention due to the completion of the Transactions; and other risks and uncertainties and the factors discussed in the section entitled “Risk Factors
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
20 Feb 24
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
8:22am
; potential difficulties in employee retention due to the announcement of the Transactions; and other risks and uncertainties and the factors discussed
6-K
GRCL
Gracell Biotechnologies Inc
17 Jan 24
Current report (foreign)
4:30pm
by the announcement of the Transactions; potential difficulties in employee retention due to the announcement of the Transactions; and other risks
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
17 Jan 24
Current report (foreign)
4:30pm
key employee retention were held at this time.
On December 12, 2023, Gracell and AstraZeneca UK Limited (“AZ UK”), an affiliate of AstraZeneca
6-K
GRCL
Gracell Biotechnologies Inc
8 Jan 24
Current report (foreign)
4:01pm
caused by the announcement of the Transactions; potential difficulties in employee retention due to the announcement of the Transactions; and other
6-K
EX-99.1
e9jt2e3hp8g7k n1qx5
29 Dec 23
Current report (foreign)
6:51pm
6-K
EX-99.2
sx0wtoidf0cndtxnvo
26 Dec 23
Voting and Support Agreement
8:12am
6-K
g21omly
26 Dec 23
Voting and Support Agreement
8:12am
6-K
EX-99.3
b4zll 0f7b
26 Dec 23
Voting and Support Agreement
8:12am
- Prev
- 1
- Next